PANBIO™ COVID-19 Ag Rapid Nasal Test Device


The Rapid Response™ COVID-19 Antigen Rapid Test Device detects the presence of SARS-CoV-2 viral nucleoprotein antigens in nasal and nasopharyngeal secretions.

In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test. 

Antigens are generally detectable in nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but other diagnostic information is necessary to determine infection status.

Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.

  • 25 test kits per box
  • 25 buffer ampules per box
  • 1 buffer solution bottle per box
  • Fast identification of potentially contagious individual
  • Test results in 15 minutes 
  • Any trained person can administer the swab 
  • Can be used in a variety of non-laboratory settings
  • Sensitivity: 91.4% (94.1% for samples with Ct values =33)
  • Specificity: 99.8% 
  • Self-contained tube with “break off” swab minimizes staff exposure
  • Extraction tube is fully enclosed for disposal
  • Accessible solution for large-scale testing

Note: Rapid Tests are FINAL SALE – All orders for this product are non-cancellable and non-refundable. 

Panbio Nasal Brochure

Out of stock

Additional information

Weight0.6 kg
Dimensions22.8 × 15.2 × 15.2 cm